BioLargo subsidiary Clyra Medical Technologies adds medical industry veterans to board of directors | News Direct

BioLargo subsidiary Clyra Medical Technologies adds medical industry veterans to board of directors

News release by BioLargo Inc

facebook icon linkedin icon twitter icon pinterest icon email icon New York | February 27, 2023 01:09 PM Eastern Standard Time

BioLargo CEO Dennis Calvert joined Proactive's Natalie Stoberman to share more details of the addition of Nicholas Valeriani and Linda Park to the board of directors of subsidiary Clyra Medical Technologies.

BioLargo noted that Valeriani has decades of executive experience in the medical device industry. He spent 34 years at Johnson & Johnson, where he led several corporate functions and was a member of its executive committee.

Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies at the corporate board and executive level at billion-dollar corporations.

 

 

Contact Details

 

Proactive USA

 

+1 347-449-0879

 

na-editorial@proactiveinvestors.com

Tags

proactiveinvestorsbiolargoOTCQBBLGOboardofdirectorscleantechlifesciencesinvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews